Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Poster
P022
Atogepant demonstrates early functional and quality of life improvements for the preventive treatment of episodic migraine after prior inadequate response to treatment: results from the ELEVATE trial
Presented in
ePoster 02
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy